Feasibility of using contrast-free quantitative magnetic resonance imaging for liver sparing stereotactic ablative body radiotherapy
This study has, for the first time, demonstrated the use of cT1 maps in radiotherapy showing significant reductions in dose to the healthy liver. Further work is needed to validate this in liver cancer patients, who would likely benefit most.
Authors
- Zoe Middleton
- Alan McWilliam (ORCID: https://orcid.org/0000-0002-7344-2868)
- Frank Brewster (ORCID: https://orcid.org/0000-0002-6105-8375)
- Robert Chuter (ORCID: https://orcid.org/0000-0002-0074-5120)
- Andrew Brocklehurst (ORCID: https://orcid.org/0000-0003-4089-5825)
- Ganesh Radhakrishna (ORCID: https://orcid.org/0000-0002-6096-9695)
Institutions
- Leeds Teaching Hospitals NHS Trust (GB)
- Manchester Academic Health Science Centre (GB)
- The Christie NHS Foundation Trust (GB)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1016/j.ctro.2024.100859
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancer Research UK
- National Institute for Health and Care Research
- Cancer Research UK Manchester Centre
- Manchester Biomedical Research Centre